FICF is WHO Collaborating Center for Research and Training in Pharmacoepidemiology. We carry out numerous activities in collaboration with agencies and institutions in other countries.
Since its creation and in accordance with its founding objectives, FICF has played an important role in disseminating different aspects of Pharmacoepidemiology and Therapeutics, advising on drug policies and promoting the reasoned use of medicines in other countries, Especially in Latin America.
Since 1982, more than 100 health professionals from Argentina, Bolivia, Brazil, Costa Rica, Colombia, Cuba, Ecuador, Guatemala, Mexico, Nicaragua, Panama, Peru, Dominican Republic, Venezuela, Chile, Mozambique and Namibia, come to make training stays between 4 months and 5 years at FICF, both to train and to develop research projects.
FICF has played an important role in the development of the WHO List of Essential Medicines since its inception in 1977 and subsequent revisions and created the 1991 DURG-LA network of Latin American health professionals.
Activities with the WHO Drug Policy Department
Since its creation, FICF has collaborated in a number of WHO activities related to the field of medicines and Pharmacoepidemiology. Some of its members act as temporary consultants or experts in projects, working groups and committees, especially the Department of Medicines Policy (DPM)
One of the most outstanding activities is the participation in the Committee for Essential Medicines, which meets every two years in Geneva in order to update the Model List of Essential Medicines. Joan-Ramon Laporte has been Chairman of this Committee between 2000 and 2006.
Since 1999, we have been involved in different WHO DPM projects related to the impact assessment of the TRIPS agreements on price and access to medicines. We have also compiled bibliographies on this subject based on information from SIETES .
We have participated in specific courses directed to Regulatory Authorities of several countries of Latin America and Asia and in educational projects like the Guide of Good Prescription (es) .
In terms of research, we are part of the coordinating team of the International Comparative Study on Drug Information (ICSODI) project on the quality of drug information in more than 20 countries.
FICF has been involved in the design and development of medicines and therapeutic information products in different countries and in collaboration with
different national and international institutions and agencies (UNICEF, WHO-PAHO, World Bank, AECI, etc...).
Some products are:
- Bulletins (Ghana, Nicaragua, Cuba, Argentina)
- Drug forms (South Africa, Nicaragua, Cuba, Peru)
- Drug information centers (Nicaragua, Cuba, Dominican R., Namibia)
FICF has participated in numerous training and research projects for health professionals in different spheres and
countries, in collaboration with international organizations (WHO-PAHO, World Bank) or national (ministries of health, universities).
Some activities and courses are:
- Courses and workshops for Regulatory Authorities (Malaysia, Thailand, Bolivia, Venezuela)
- Practical workshops on drug use studies (Managua, Corrientes, Ciudad del Este, Caracas, Maracaibo, Porto Alegre, Montevideo)
- Training on topics related to pharmacovigilance (Guatemala, Sao Paulo, Nicaragua, Panama) and training activities of AEMPS / AECI
- Problem-based undergraduate teaching Guide to Good Prescription (es)
At an international level, FICF has participated in several multinational research projects. Here we describe the research activity developed with
the support of international organizations (WHO-PAHO) or projects carried out with the support of national institutions in several countries.
- Multicenter Project on the Quality of Medication Information (ICSODI)
- Pharmacovigilance and drug use studies in Latin America
- Studies carried out within the DURG-LA
FICF is registered as a Non-Governmental Development Organizations (NGDOs) of the Spanish Agency for Cooperation and Development (
AECID ). Since 2003, we have been
developing some cooperation projects that have received support from the Catalan Agency for Development Cooperation (
ACCD ) (years 2003, 2004 and 2005).
These cooperation projects are related to two of the Millennium Development Goals:
Millennium Development Goal number 5
Project International Group for the Reduction of Mortality and Morbility Associated with Puerperal Hemorrhage (GIRMMAHP) to reduce maternal morbidity and mortality associated with puerperal hemorrhage
Millennium Development Goal number 4
Project International Group for the Reduction of Mortality and Morbility Associated with Puerperal Hemorrhage (IMAPIAC) to improve attention to respiratory problems in children.
We believe that networking is fundamental, especially in areas with few professionals dedicated to the topic and/or
when it is necessary to overcome important geographical distances.
FICF has launched and / or participates in various international networks related to Pharmacoepidemiology:
- DURG-LA (scope: Latin America and Spain, created by FICF 1991)
- Collaboration through the use of Intranet (example, GIRMMAHP)
- Cuban Network of Pharmacoepidemiology (created in 1996)
- International pharmacovigilance network